<table cellpadding="0" cellspacing="0" border="1"><tr><td></td><td>For the Years Ended December 31,</td><td>For the Years Ended December 31,</td><td>For the Years Ended December 31,</td></tr>
<tr><td></td><td>2013</td><td>2012</td><td>2011</td></tr>
<tr><td>Cash Flows From Operating Activities</td><td>-</td><td>-</td><td>-</td></tr>
<tr><td>Net (loss) income</td><td>-6,072</td><td>50,985</td><td>24,098</td></tr>
<tr><td>Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:</td><td>-</td><td>-</td><td>-</td></tr>
<tr><td>Depreciation and amortization</td><td>241</td><td>-</td><td>-</td></tr>
<tr><td>Stock-based compensation expense</td><td>1,189</td><td>-</td><td>-</td></tr>
<tr><td>Shares received in settlement of litigation</td><td>-</td><td>-8,353</td><td>-</td></tr>
<tr><td>Shares received in exchange for modification of license agreement</td><td>-</td><td>-3,116</td><td>-</td></tr>
<tr><td>Gain on sale of patents</td><td>-</td><td>-</td><td>-1,280</td></tr>
<tr><td>Tax provision contributed by Former Parent</td><td>-263</td><td>1,564</td><td>2,704</td></tr>
<tr><td>Changes in operating assets and liabilities:</td><td>-</td><td>-</td><td>-</td></tr>
<tr><td>Accounts receivable</td><td>152</td><td>-</td><td>-</td></tr>
<tr><td>Inventories</td><td>94</td><td>-</td><td>-</td></tr>
<tr><td>Prepaid expenses and other current assets</td><td>-82</td><td>-3</td><td>-</td></tr>
<tr><td>Other assets</td><td>-23</td><td>-</td><td>-</td></tr>
<tr><td>Accrued expenses</td><td>-346</td><td>68</td><td>-</td></tr>
<tr><td>Accounts payable</td><td>-2,331</td><td>1,740</td><td>389</td></tr>
<tr><td>Accounts payable - related parties</td><td>-2</td><td>2</td><td>-</td></tr>
<tr><td>Accrued income taxes</td><td>-25,321</td><td>24,633</td><td>691</td></tr>
<tr><td>Deferred tax liability</td><td>-4</td><td>-</td><td>-</td></tr>
<tr><td>Total Adjustments</td><td>-26,696</td><td>16,535</td><td>2,504</td></tr>
<tr><td>Net Cash (Used in) Provided By Operating Activities</td><td>-32,768</td><td>67,520</td><td>26,602</td></tr>
<tr><td>Cash Flows From Investing Activities</td><td>-</td><td>-</td><td>-</td></tr>
<tr><td>Purchases of shares in investee</td><td>-500</td><td>-1,601</td><td>-</td></tr>
<tr><td>Proceeds from sale of shares in investee</td><td>-</td><td>286</td><td>-</td></tr>
<tr><td>Cash acquired through merger with Converted Organics</td><td>63</td><td>-</td><td>-</td></tr>
<tr><td>Proceeds from notes receivable acquired through merger with Converted Organics</td><td>517</td><td>-</td><td>-</td></tr>
<tr><td>Purchases of property and equipment</td><td>-111</td><td>-</td><td>-</td></tr>
<tr><td>Proceeds from sale of patents, net of legal costs</td><td>-</td><td>-</td><td>1,280</td></tr>
<tr><td>Net Cash (Used in) Provided by Investing Activities</td><td>-31</td><td>-1,315</td><td>1,280</td></tr>
<tr><td>Cash Flows From Financing Activities</td><td>-</td><td>-</td><td>-</td></tr>
<tr><td>Repayment of loan from Former Parent</td><td>-33,943</td><td>-2,470</td><td>-157</td></tr>
<tr><td>Repurchase and retirement of common stock</td><td>-205</td><td>-</td><td>-</td></tr>
<tr><td>Net Cash Used in Financing Activities</td><td>-34,148</td><td>-2,470</td><td>-157</td></tr>
<tr><td>Net (Decrease) Increase in Cash and Cash Equivalents</td><td>-66,947</td><td>63,735</td><td>27,725</td></tr>
<tr><td>Cash and Cash Equivalents - Beginning</td><td>91,545</td><td>27,810</td><td>85</td></tr>
<tr><td>Cash and Cash Equivalents - Ending</td><td>24,598</td><td>91,545</td><td>27,810</td></tr>
</table>